Literature DB >> 29473565

Should I offer vagus nerve stimulation as part of my neurology practice?

Kai M Denski1, David M Labiner1.   

Abstract

Vagus nerve stimulation (VNS) is a safe and effective adjunctive therapy approved for patients with partial-onset seizures. A pulse generator, which is implanted in the chest wall, delivers programmed electrical pulses through an electrode that is attached to the left vagus nerve. VNS plays an important role in the treatment of patients with drug-resistant epilepsy. It is currently offered in academic as well as private practice settings. After a comprehensive workup is performed, VNS should be offered to patients with drug-resistant epilepsy who are not candidates for surgery.

Entities:  

Year:  2014        PMID: 29473565      PMCID: PMC5764528          DOI: 10.1212/CPJ.0000000000000048

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  17 in total

1.  Reassessment: vagus nerve stimulation for epilepsy: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  R S Fisher; A Handforth
Journal:  Neurology       Date:  1999-09-11       Impact factor: 9.910

2.  Vagal nerve stimulation: adjustments to reduce painful side effects.

Authors:  J Liporace; D Hucko; R Morrow; G Barolat; M Nei; J Schnur; M Sperling
Journal:  Neurology       Date:  2001-09-11       Impact factor: 9.910

Review 3.  Drug-resistant epilepsy.

Authors:  Patrick Kwan; Steven C Schachter; Martin J Brodie
Journal:  N Engl J Med       Date:  2011-09-08       Impact factor: 91.245

4.  Ventricular asystole during vagus nerve stimulation for epilepsy in humans.

Authors:  W O Tatum; D B Moore; M M Stecker; G H Baltuch; J A French; J A Ferreira; P M Carney; D R Labar; F L Vale
Journal:  Neurology       Date:  1999-04-12       Impact factor: 9.910

5.  Early identification of refractory epilepsy.

Authors:  P Kwan; M J Brodie
Journal:  N Engl J Med       Date:  2000-02-03       Impact factor: 91.245

Review 6.  Vagus nerve stimulation therapy in depression and epilepsy: therapeutic parameter settings.

Authors:  David M Labiner; Geoffrey L Ahern
Journal:  Acta Neurol Scand       Date:  2007-01       Impact factor: 3.209

Review 7.  Vagus nerve stimulation, side effects, and long-term safety.

Authors:  E Ben-Menachem
Journal:  J Clin Neurophysiol       Date:  2001-09       Impact factor: 2.177

8.  Vagus nerve stimulation for 1 year in 269 patients on unchanged antiepileptic drugs.

Authors:  Douglas Labar
Journal:  Seizure       Date:  2004-09       Impact factor: 3.184

9.  Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy.

Authors:  J Ben Renfroe; James W Wheless
Journal:  Neurology       Date:  2002-09-24       Impact factor: 9.910

10.  Trends in the use of vagus nerve stimulation for epilepsy: analysis of a nationwide database.

Authors:  Ali A Baaj; Selim R Benbadis; William O Tatum; Fernando L Vale
Journal:  Neurosurg Focus       Date:  2008-09       Impact factor: 4.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.